Literature DB >> 25851059

Efficacy of 1% acetic acid in the treatment of chronic wounds infected with Pseudomonas aeruginosa: prospective randomised controlled clinical trial.

V L Madhusudhan1.   

Abstract

Chronic wounds are those wounds that are persistent and do not respond to any sort of treatment. The concept of using topical antiseptics on open wounds is to prevent and treat infections. They also help to shorten the time taken to heal the wounds. The use of topical agents on wounds to prevent infection is a minimal ability to develop resistance to the microorganisms. Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen with innate resistance to many antibiotics. In places that are economically backward, these problems get compounded by the inability of patients to afford newer expensive drugs. Topically applied dilute acetic acid, which is cheap and easily available, has been found to be effective in such chronic wounds. In the present study, an attempt has been made to use 1% acetic acid as the sole antimicrobial agent for the treatment of pseudomonal wound infections. A control limb was used in which the wounds were treated with normal saline. Our objective was to evaluate the efficacy of acetic acid in low concentration of 1% in chronic wounds infected with P. aeruginosa. This was a prospective study conducted over a period of 6 months. INCLUSION CRITERIA: All patients with chronic wounds infected with P. aeruginosa. EXCLUSION CRITERIA: Wounds due to massive burns, suspected malignancy, immunocompromised individuals and individuals with sepsis. A total of 32 patients enrolled in the study. Subjects were randomised equally to the 1% acetic acid group and saline dressing group. None of the patients received any systemic antibiotics during the study period and received twice daily dressings. The endpoint of the treatment was wounds free of P. aeruginosa. The duration of treatment required to eliminate the Pseudomonas from the wounds in the acetic acid group was on an average 7 days less than that required by the saline group. P value was <0·001. In the 1% acetic acid group irrespective of the sensitivity of the organism to antibiotics, Pseudomonas organisms were eliminated within the same time period - 4·5 days. In the saline group, susceptible organisms were eliminated within 11·5 days and multidrug-resistant organisms were eliminated by 15·5 days. 1% acetic acid is a simple, safe and effective topical antiseptic that can be used in the elimination of P. aeruginosa from chronic infected wounds.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  1% Acetic acid; Multidrug resistant; Normal saline; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2015        PMID: 25851059      PMCID: PMC7949569          DOI: 10.1111/iwj.12428

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  30 in total

Review 1.  Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.

Authors:  J B Lyczak; C L Cannon; G B Pier
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

Review 2.  Preparing the wound bed 2003: focus on infection and inflammation.

Authors:  R Gary Sibbald; Heather Orsted; Gregory S Schultz; Patricia Coutts; David Keast
Journal:  Ostomy Wound Manage       Date:  2003-11       Impact factor: 2.629

Review 3.  What's new in burn microbiology? James Laing Memorial Prize Essay 2000.

Authors:  Valerie Edwards-Jones; John E Greenwood
Journal:  Burns       Date:  2003-02       Impact factor: 2.744

Review 4.  A critical discussion of the use of antiseptics in acute traumatic wounds.

Authors:  Robert G Smith
Journal:  J Am Podiatr Med Assoc       Date:  2005 Mar-Apr

5.  How bacteria stick.

Authors:  J W Costerton; G G Geesey; K J Cheng
Journal:  Sci Am       Date:  1978-01       Impact factor: 2.142

6.  Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression.

Authors:  Lucinda J Thompson; D Scott Merrell; Brett A Neilan; Hazel Mitchell; Adrian Lee; Stanley Falkow
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 7.  Revolutionary advances in the management of traumatic wounds in the emergency department during the last 40 years: part I.

Authors:  Richard F Edlich; George T Rodeheaver; John G Thacker; Kant Y Lin; David B Drake; Shelley S Mason; Courtney A Wack; Margot E Chase; Curt Tribble; William B Long; Robert J Vissers
Journal:  J Emerg Med       Date:  2009-03-05       Impact factor: 1.484

8.  Mechanisms of delayed wound healing by commonly used antiseptics.

Authors:  Gregory W Thomas; Leonard T Rael; Raphael Bar-Or; Richard Shimonkevitz; Charles W Mains; Denetta Sue Slone; Michael L Craun; David Bar-Or
Journal:  J Trauma       Date:  2009-01

9.  The clinical significance of bacterial growth in venous leg ulcers.

Authors:  G Eriksson; A E Eklund; L O Kallings
Journal:  Scand J Infect Dis       Date:  1984

Review 10.  Biofilms: microbial life on surfaces.

Authors:  Rodney M Donlan
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more
  12 in total

1.  Topical Antimicrobials in Burn Care: Part 1-Topical Antiseptics.

Authors:  Janos Cambiaso-Daniel; Stafanos Boukovalas; Genevieve H Bitz; Ludwik K Branski; David N Herndon; Derek M Culnan
Journal:  Ann Plast Surg       Date:  2018-01-09       Impact factor: 1.539

Review 2.  Antiseptics for burns.

Authors:  Gill Norman; Janice Christie; Zhenmi Liu; Maggie J Westby; Jayne M Jefferies; Thomas Hudson; Jacky Edwards; Devi Prasad Mohapatra; Ibrahim A Hassan; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

Review 3.  The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice.

Authors:  Ut T Bui; Kathleen Finlayson; Helen Edwards
Journal:  Int Wound J       Date:  2019-01-29       Impact factor: 3.315

Review 4.  Infection in Venous Leg Ulcers: Considerations for Optimal Management in the Elderly.

Authors:  Douglas J Pugliese
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

5.  Non-invasive nanosecond electroporation for biocontrol of surface infections: an in vivo study.

Authors:  Vitalij Novickij; Auksė Zinkevičienė; Emilija Perminaitė; Robertas Čėsna; Eglė Lastauskienė; Algimantas Paškevičius; Jurgita Švedienė; Svetlana Markovskaja; Jurij Novickij; Irutė Girkontaitė
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

6.  Pyrodextrin enhances intestinal function through changing the intestinal microbiota composition and metabolism in early weaned piglets.

Authors:  Lihui Zhu; Rongrong Liao; Weilong Tu; Yonghong Lu; Xuan Cai
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-03       Impact factor: 4.813

Review 7.  Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature.

Authors:  Sabina Fijan; Anita Frauwallner; Tomaž Langerholc; Bojan Krebs; Jessica A Ter Haar Née Younes; Adolf Heschl; Dušanka Mičetić Turk; Irena Rogelj
Journal:  Biomed Res Int       Date:  2019-12-12       Impact factor: 3.411

Review 8.  Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering.

Authors:  Hossein Sadidi; Sara Hooshmand; Ali Ahmadabadi; Seyed Javad Hosseini; Francesco Baino; Morvarid Vatanpour; Saeid Kargozar
Journal:  Molecules       Date:  2020-10-06       Impact factor: 4.411

Review 9.  Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.

Authors:  Marina Gomes Machado; Valentin Sencio; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

Review 10.  Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the 'Chink in the Armor'?

Authors:  Snehal Kadam; Saptarsi Shai; Aditi Shahane; Karishma S Kaushik
Journal:  Biomedicines       Date:  2019-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.